Which Criteria are More Valuable in Defining Hemodynamic Significance of Patent Ductus Arteriosus in Premature Infants? Respiratory or Echocardiographic?
Özet
Aim: Patent ductus arteriosus (PDA) is a frequent health problem in premature infants. Pharmacologic closure is recommended only for hemodynamically significant PDA (hsPDA) that is defined according to the clinical and echocardiographic criteria. The aim of this study was to explore the value of commonly used criteria in defining hsPDA and predicting the required number of courses of ibuprofen treatment to close PDA in premature infants.
Atıf için künye
ŞAHİN, I. O., YOLCU, C., ŞAHİN, A. E., Kara, M., Demirelli, Y., Olgun, H., & Ceviz, N. (2017). Which Criteria are More Valuable in Defining Hemodynamic Significance of Patent Ductus Arteriosus in Premature Infants? Respiratory or Echocardiographic? Haseki Tip Bulteni, 55(1), 32–36. https://doi.org/10.4274/haseki.3278
BibTeX
@article{sahin2017-223418,
author = {ŞAHİN, Irfan Oguz and YOLCU, Canan and ŞAHİN, Aysegul Elbir and Kara, Mustafa and Demirelli, Yaşar and Olgun, Haşim and Ceviz, Naci},
title = {Which Criteria are More Valuable in Defining Hemodynamic Significance of Patent Ductus Arteriosus in Premature Infants? Respiratory or Echocardiographic?},
journal = {Haseki Tip Bulteni},
year = {2017},
volume = {55},
number = {1},
pages = {32--36},
issn = {1302-0072},
doi = {10.4274/haseki.3278},
url = {https://akademik.atauni.edu.tr/yayinlar/223418-which-criteria-are-more-valuable-in-defining-hemodynamic-significance-of-patent}
}